Trial Profile
Phase I Dose Escalation of Vandetanib (Zactima, ZD6474) in Combination With Etoposide for Malignant Gliomas.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 May 2021
Price :
$35
*
At a glance
- Drugs Vandetanib (Primary) ; Etoposide
- Indications Glioma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 20 Nov 2012 Planned end date changed from 1 Jun 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
- 17 Feb 2012 Planned End Date changed from 1 Jan 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 03 Feb 2011 Planned End Date changed from 1 May 2012 to 1 Jan 2012 as reported by ClinicalTrials.gov.